Succeeding
in Global Strategic Marketing for Strong Oncology Launches
Managing all the aspects
of successfully launching a new oncology product is a daunting endeavor that
often falls to the Global Strategic Marketing (GSM) function. As the oncology
market continues to be a rapid growth area for the biopharmaceutical industry,
leaders must continually assess their budgets, investment strategies, staffing,
structure and scope of services.
According to recent
research Global Strategic Marketing organizations are shifting their budgets to
better fit their current needs. Budget increases are anticipated by as much as
73% of benchmark participants for activities supporting the Oncology pipeline.
Few participants project any decreases in their budgets for this area.
The related report,
"Oncology Global Strategic Marketing: Benchmarking Budget Levels &
Service Scope," will help GSM leaders in oncology to better evaluate and
improve their global strategic marketing programs. The study will allow leaders
to understand the investment levels, marketing activities, timing, and
structures needed to successfully steer products and pipeline programs through
the complex oncology marketplace.
The 75-page study provides
current benchmarks, such as:
GSM staffing benchmarks by
role, by development phase, by number of oncology programs and per $100M in
oncology sales
Outsourced and in-house
labor dedicated to traditional and emerging markets
GSM organizational
structure
Role of the GSM function
for activities such as market intelligence, marketing, advocacy and KOL
management
Spending benchmarks around
key GSM activities within marketing, market intelligence and advocacy
Oncology GSM spending by
phase of clinical development
The study engaged GSM
leaders supporting Oncology organizations at 17 companies. The study included
both large, established and small, emerging Oncology companies to provide the
broadest insights. Data is presented for large and emerging company segments
throughout the report.
To access the full report,
or to download a complimentary summary containing insights found in this
report, click on the following link: http://www.best-in-class.com/rr1307.htm
For more information on
other recent primary research studies, contact us at 919.403.0251. For related
research, visit our Best Practices, LLC website at
http://www.best-in-class.com/.
ABOUT BEST PRACTICES, LLC
Best Practices, LLC is a
leading benchmarking, consulting and advisory services firm serving
biopharmaceutical and medical device companies worldwide. Best Practices, LLC's
clients include all the top 10 and 48 of the top 50 global healthcare
companies. The firm conducts primary research and consulting using its
comprehensive proprietary benchmarking tools and analysis. The operational
insights, findings and analysis form the basis for our Benchmarking Reports,
databases and advisory services to support executives in commercial and R&D
operations. Best Practices, LLC believes in the profound principle that
organizations can chart a course to superior economic performance by studying
the best business practices, operating tactics and winning strategies of
world-class companies.
No comments:
Post a Comment